In The News
CIDRZ Receives Grant from the Bill & Melinda Gates Foundation to Identify Ways to Retain HIV-Infected Persons in Care
WASHINGTON, DC, August 28, 2014 - Accordia Global Health Foundation congratulates the Centre for Infectious Disease Research in Zambia (CIDRZ) and CIDRZ CEO, Dr. Charles Holmes, Deputy CEO, Dr. Izukanji Sikazwe, and Dr Elvin Geng of the University of California San Francisco (UCSF) on the receipt of a $4.76 million award from the Bill & Melinda Gates Foundation to support the Better Information for Health in Zambia study.
The purpose of the Better Information for Health in Zambia study is to more accurately measure loss to follow-up, and to determine the factors that lead to as many as 40% of HIV-infected patients to fall out of enrolled antiretroviral (ART) treatment programs in Zambia. More accurate estimates of the outcomes of HIV patients enrolled in care will assist the Zambian government to make informed decisions about HIV care service provision so that health programs and facilities better meet the needs of their HIV-infected patients, keeping them in care and returning them to health.
The ‘Better Info’ study is collaboration between CIDRZ, UCSF, and includes multiple Zambian and other co-Investigators from the University of Alabama at Birmingham, and the University of North Carolina, Chapel Hill.
Learn More About the Study
Established in Zambia in 2001 as an extension of an U.S. university, CIDRZ became an independent organization in 2011. This grant is one important demonstration that new CIDRZ leadership has effectively managed the transition to local ownership – while enhancing the quality of its programs and the accountability of its management systems.
Accordia is proud to support a network of
Sustainable African Health Institutions
like CIDRZ (www.cidrz.org). Permanent, locally-owned African organizations, operating at world class standards, in collaboration with individuals and institutions around the world.
